175 related articles for article (PubMed ID: 31140551)
1. Activation of the NF-κB Pathway and Heterozygous Deletion of TNFAIP3 (A20) Confer Superior Survival in Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
Liu F; Zheng JP; Wang L; Zhao DH; Li MY; Wang YM; Liu Y; Ma J; Zeng NY; Liu HX; Liang R; Guo SP; Wang Z; Yan QG
Am J Clin Pathol; 2019 Jul; 152(2):243-252. PubMed ID: 31140551
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic implications of TNFAIP3/A20 deletions in extranodal NK/T-cell lymphoma.
Ahn H; Yang JM; Jeon YK; Paik JH
Genes Chromosomes Cancer; 2018 May; 57(5):231-239. PubMed ID: 29380463
[TBL] [Abstract][Full Text] [Related]
3. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP3/NF-κB/SMAD pathway in patients with immune thrombocytopenia.
He Y; Xu LL; Feng FE; Wang QM; Zhu XL; Wang CC; Zhang JM; Fu HX; Xu LP; Liu KY; Huang XJ; Zhang XH
Br J Haematol; 2018 Feb; 180(3):395-411. PubMed ID: 29327472
[TBL] [Abstract][Full Text] [Related]
5. A20 (TNFAIP3) Alterations in Primary Intestinal Diffuse Large B-cell Lymphoma.
Fujii M; Takata K; Chuang SS; Miyata-Takata T; Ando M; Sato Y; Yoshino T
Acta Med Okayama; 2018 Feb; 72(1):23-30. PubMed ID: 29463935
[TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation in TNFAIP3 causes haploinsufficiency of A20.
Jiang W; Deng M; Gan C; Wang L; Mao H; Li Q
Cell Immunol; 2022 Jan; 371():104453. PubMed ID: 34808442
[TBL] [Abstract][Full Text] [Related]
7. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
8. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling.
Ng SB; Selvarajan V; Huang G; Zhou J; Feldman AL; Law M; Kwong YL; Shimizu N; Kagami Y; Aozasa K; Salto-Tellez M; Chng WJ
J Pathol; 2011 Mar; 223(4):496-510. PubMed ID: 21294123
[TBL] [Abstract][Full Text] [Related]
9. Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.
Montesinos-Rongen M; Schmitz R; Brunn A; Gesk S; Richter J; Hong K; Wiestler OD; Siebert R; Küppers R; Deckert M
Acta Neuropathol; 2010 Oct; 120(4):529-35. PubMed ID: 20544211
[TBL] [Abstract][Full Text] [Related]
10. Synergistic activation of NF-κB by TNFAIP3 (A20) reduction and UBE2L3 (UBCH7) augment that synergistically elevate lupus risk.
Kim T; Bae SC; Kang C
Arthritis Res Ther; 2020 Apr; 22(1):93. PubMed ID: 32334614
[TBL] [Abstract][Full Text] [Related]
11. The mutational landscape of ocular marginal zone lymphoma identifies frequent alterations in TNFAIP3 followed by mutations in TBL1XR1 and CREBBP.
Jung H; Yoo HY; Lee SH; Shin S; Kim SC; Lee S; Joung JG; Nam JY; Ryu D; Yun JW; Choi JK; Ghosh A; Kim KK; Kim SJ; Kim WS; Park WY; Ko YH
Oncotarget; 2017 Mar; 8(10):17038-17049. PubMed ID: 28152507
[TBL] [Abstract][Full Text] [Related]
12. Aggressive natural killer (NK)-cell leukaemia and extranodal NK/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings.
Yang CF; Hsu CY; Ho DM
Histopathology; 2018 May; 72(6):955-964. PubMed ID: 29314186
[TBL] [Abstract][Full Text] [Related]
13. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
[TBL] [Abstract][Full Text] [Related]
14. High throughput sequencing reveals high specificity of TNFAIP3 mutations in ocular adnexal marginal zone B-cell lymphomas.
Vela V; Juskevicius D; Gerlach MM; Meyer P; Graber A; Cathomas G; Dirnhofer S; Tzankov A
Hematol Oncol; 2020 Aug; 38(3):284-292. PubMed ID: 32012328
[TBL] [Abstract][Full Text] [Related]
15. A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models.
Das T; Chen Z; Hendriks RW; Kool M
Front Immunol; 2018; 9():104. PubMed ID: 29515565
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Expression of Prohibitin Is Related to Prognosis of Nasal Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
Guo WW; Chen LH; Yin W; Mo LX
Oncol Res Treat; 2020; 43(10):491-497. PubMed ID: 32756049
[TBL] [Abstract][Full Text] [Related]
17. DNGR1-mediated deletion of A20/Tnfaip3 in dendritic cells alters T and B-cell homeostasis and promotes autoimmune liver pathology.
Das T; Bergen IM; Koudstaal T; van Hulst JAC; van Loo G; Boonstra A; Vanwolleghem T; Leung PSC; Gershwin ME; Hendriks RW; Kool M
J Autoimmun; 2019 Aug; 102():167-178. PubMed ID: 31151831
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
[TBL] [Abstract][Full Text] [Related]
19. TNFAIP3 overexpression is an independent factor for poor survival in esophageal squamous cell carcinoma.
Hadisaputri YE; Miyazaki T; Yokobori T; Sohda M; Sakai M; Ozawa D; Hara K; Honjo H; Kumakura Y; Kuwano H
Int J Oncol; 2017 Mar; 50(3):1002-1010. PubMed ID: 28197630
[TBL] [Abstract][Full Text] [Related]
20. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
